The impact of generic substitution on the activities of pharmaceutical companies - a survey from the companies' perspective one year and five years after the introduction of generic substitution in finland |
| |
| Authors: | Johanna Timonen Marina Bengtström Pekka Karttunen Riitta Ahonen |
| |
| Affiliation: | 1.School of Pharmacy/Social Pharmacy, Faculty of Health Sciences, Kuopio Campus,University of Eastern Finland,Kuopio,Finland;2.Pharma Industry Finland,Helsinki,Finland;3.Siilinj?rvi pharmacy,Siilinj?rvi,Finland |
| |
| Abstract: | Background Mandatory generic substitution (GS) was introduced in Finland on 1 April 2003. The aim of this study was to explore and compare the impacts of GS on the activities of pharmaceutical companies representing mainly original or generic pharmaceutical products in Finland. The self-reported impact of GS from pharmaceutical companies' perspective was explored with a focus on the number of employees, the range of sales packages on the market, the marketing activities, the research and development of new pharmaceutical products and storage of pharmaceuticals. |
| |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ |
|
